ONK Announcement (IMAGE) Trinity College Dublin Caption Galway based life science company, ONK Therapeutics has been awarded an Innovation Partnership Programme grant by Enterprise Ireland to fund collaborative research at Trinity College Dublin on optimising the metabolism of Natural Killer (NK) cells for use in potent new cancer therapies. ONK Therapeutics was founded in Galway in 2015. It is focused on cutting edge NK cell therapies in cancer treatments and has raised over €10 million in the past 14 months from investors including US based Acorn Bioventures and Irish based life science entrepreneur Seamus Mulligan. Credit ONK Therapeutics and Trinity College Dublin. Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.